Written by Patrick O'Connor
Published on Vol 6 Issue 1, 2026
Chemical standardization is central to the quality control of herbal medicines, yet reproducible constituent content does not necessarily produce reproducible systemic exposure. This translational review examines why that gap persists by integrating evidence on product matrix, co-constituent interactions, dose and administration, host physiology, metabolism, transport, microbiota, formulation, and bioanalytical measurement. The selected literature indicates that exposure is generated downstream
Written by Gabriel Costa
Published on Vol 6 Issue 1, 2026
Natural-product machine-learning models do not encounter molecules, spectra, organisms, or biological responses directly; they encounter database records produced through choices about what is deposited, normalized, linked, corrected, omitted, and retained. This article develops an original data-governance architecture for natural-product modeling that treats these choices as part of the inferential system rather than as background data-management operations. The analysis integrates structural i
Written by Luca Ferraro
Published on Vol 6 Issue 1, 2026
Reconstructing medicinal-plant biosynthetic pathways increasingly requires more than identifying enzymes, pathway genes, and candidate regulatory relationships. Conventional genomic, transcriptomic, biochemical, and heterologous-reconstruction approaches can establish pathway membership and reaction competence while leaving unresolved where pathway steps occur within intact tissues, whether intermediates move between cell types, and whether metabolite accumulation identifies synthesis, transport
Written by Pieter Botha
Published on Vol 6 Issue 1, 2026
Reconstructing plant natural-product pathways outside their native organisms is often framed as a choice among established production hosts, yet pathway success depends on biochemical requirements that differ substantially among molecules. Yeast, bacterial, and plant-cell systems offer distinct combinations of membrane organization, redox physiology, precursor metabolism, transport capacity, compartmentation, tolerance, and engineering accessibility. Consequently, a chassis that performs well fo
Written by Santiago Morales
Published on Vol 6 Issue 1, 2026
Natural-product structure prioritization increasingly uses machine-learning models that map tandem mass spectra, nuclear magnetic resonance data, or combinations of spectral modalities to candidate structures. Yet a high model score does not establish that a query lies within the chemistry, acquisition conditions, spectral information regime, or candidate space represented during model development. This distinction matters especially for natural products, where scaffold novelty, sparse reference
Written by Nora Schneider
Published on Vol 6 Issue 1, 2026
Natural products can produce rich phenotypic, transcriptional, morphological, and proteomic responses while leaving the molecular cause of those responses uncertain. Contemporary target-discovery approaches increasingly connect compound perturbations with omics signatures, predicted targets, proteome-wide engagement, genetic sensitivity, and pathway effects, but these observations do not carry equivalent causal meaning. This article develops a proposed causal evidence architecture for separating
Written by Daniel Kim
Published on Vol 6 Issue 1, 2026
Batch-to-batch consistency in complex herbal preparations is commonly judged through identity tests, marker assays, chromatographic fingerprints, and multivariate similarity. These approaches are essential for chemical quality control, yet they do not by themselves establish that manufacturing or storage variation has preserved the chemical features most relevant to biological function. This article develops an original quality-equivalence model that reframes batch equivalence as a multiscale ev
Written by Mateo Alvarez
Published on Vol 6 Issue 1, 2026
Medicinal-plant provenance is commonly recorded as a geographic property, yet climate instability increasingly challenges the assumption that material collected from the same named region will retain a chemically comparable state across years, seasons, developmental stages, and harvest conditions. This article develops an original provenance-risk model for medicinal plants that treats provenance as a dynamic combination of botanical identity, environmental exposure, developmental state, harvest
Written by Sara Ben Youssef
Published on Vol 6 Issue 1, 2026
Microbial natural-product manufacturing is usually optimized as though one dominant limitation can be identified, corrected, and then managed through scale-up. That assumption is increasingly difficult to sustain because pathway capacity, precursor allocation, product or intermediate toxicity, oxygen and substrate delivery, mixing, energy demand, and recovery can become restrictive at different process states and reactor scales. This article develops an original bioprocess architecture in which
Written by Noah Williams
Published on Vol 6 Issue 1, 2026
Structure elucidation is commonly reported as a definitive molecular drawing even when the evidential basis for connectivity, relative configuration, and absolute configuration is uneven. This reporting convention compresses heterogeneous analytical support, model dependence, unresolved alternatives, and method-specific uncertainty into a single visual endpoint. This article develops an original analytical evidence model in which structure elucidation terminates instead in a level-specific confi
Written by Elena Petrova
Published on Vol 6 Issue 1, 2026
Natural products are frequently described as polypharmacological because multiple proteins, pathways, or phenotypes become associated with a single compound. Yet target multiplicity can arise from fundamentally different evidentiary processes, including database aggregation, computational prediction, assay interference, nonspecific activity, proteomic target engagement, or functionally consequential interactions. Treating these states as mechanistically equivalent risks converting annotation den
Written by Lina Hassan
Published on Vol 6 Issue 1, 2026
The recurrent detection of the same specialized metabolite in a plant and one of its endophytes is frequently interpreted as evidence that both partners possess the capacity to synthesize that compound. This inference is stronger than the observation itself. Shared chemistry can arise through autonomous biosynthesis, host metabolic induction, microbial pathway activation, metabolite or precursor exchange, biotransformation, cultivation-dependent expression, or analytical misassignment. This arti
Written by Saif Al-Hinai
Published on Vol 6 Issue 1, 2026
Complex herbal formulas are often interpreted through the language of synergy, yet the observation that a combination behaves differently from its isolated components does not identify where the interaction occurs or whether the effect satisfies a formal pharmacological definition of synergy. This article develops an original layered interaction model that separates three analytically distinct domains: chemical interactions that alter material state or constituent availability before systemic ex
Written by Charlotte Dupuis
Published on Vol 6 Issue 1, 2026
Natural-product pharmacology has conventionally inferred activity from averaged biochemical, cellular, tissue, or organism-level measurements. These approaches remain indispensable, but averaging can obscure which cellular states respond, which remain refractory, where pharmacologically relevant species accumulate, and whether apparent pathway normalization reflects direct action or changing cellular composition. Single-cell and spatial technologies create a complementary analytical layer by res
Written by Olivia Bennett
Published on Vol 6 Issue 1, 2026
Many phytochemicals combine pharmacological interest with low or variable oral systemic exposure arising from poor aqueous solubility, dissolution limitations, gastrointestinal instability, permeability constraints, efflux, and extensive presystemic metabolism. Formulation technologies are frequently presented as solutions, yet improvement in formulation performance is not equivalent to demonstrated improvement in systemic exposure, and exposure enhancement does not itself establish therapeutic
Written by Ethan Wright
Published on Vol 6 Issue 1, 2026
Artificial intelligence is increasingly embedded in natural-product structure elucidation, but the term encompasses methodologically distinct operations whose outputs carry different evidential meanings. This methodological review examines where AI enters the elucidation workflow, how spectral prediction and inverse inference differ, how candidates are generated and ranked, how complementary analytical modalities can be integrated, and why confidence and human verification remain separate proble
Written by Yifan Zhao
Published on Vol 6 Issue 1, 2026
Complex natural-product pathways are increasingly reconstructed outside their native organisms, yet successful biosynthesis is often interpreted too broadly as evidence of pathway portability or manufacturing readiness. Cell-free and cell-based systems solve different parts of this problem and expose different constraints. We conducted a qualitative evidence-mapping review of peer-reviewed Q1-journal literature published from 2017 through 2026. Searches covered cell-free biosynthesis, heterologo
Established in 2019, Galaxy Publication stands as a global academic publishing house focused on advancing scholarly work across medicine, nursing, and health sciences. Through its network of peer-reviewed journals, the organization brings together original research and academic contributions from scholars around the world, creating a shared space for knowledge exchange and intellectual collaboration.
